Use of Calcium Channel Blockers and Parkinson’s Disease

The Danish National Prescription Registry

(2011) Helle Wallach Kildemoes et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Calcium channel blocker use and risk of Parkinson's disease

(2010) Kelly Claire Simon et al.   MOVEMENT DISORDERS

PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death

(2009) Sonia Gandhi et al.   MOLECULAR CELL

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

(2009) Wataru Satake et al.   NATURE GENETICS

Antihypertensive Agents and Risk of Parkinson’s Disease, Essential Tremor and Dementia: A Population-Based Prospective Study (NEDICES)

(2009) Elan D. Louis et al.   NEUROEPIDEMIOLOGY

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

(2009) C. Warren Olanow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Calcium signaling and neurodegenerative diseases

(2009) Ilya Bezprozvanny   TRENDS IN MOLECULAR MEDICINE

Use of antihypertensives and the risk of Parkinson disease

(2008) C. Becker et al.   NEUROLOGY